Agilent Technologies, Inc. $A Shares Purchased by University of Texas Texas AM Investment Management Co.

University of Texas Texas AM Investment Management Co. boosted its holdings in Agilent Technologies, Inc. (NYSE:A) by 57.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 11,652 shares of the medical research company’s stock after acquiring an additional 4,240 shares during the quarter. University of Texas Texas AM Investment Management Co.’s holdings in Agilent Technologies were worth $1,585,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in the business. USS Investment Management Ltd increased its position in Agilent Technologies by 1.3% in the 4th quarter. USS Investment Management Ltd now owns 113,879 shares of the medical research company’s stock valued at $15,500,000 after acquiring an additional 1,515 shares during the period. Vanguard Personalized Indexing Management LLC increased its position in Agilent Technologies by 2.6% in the 4th quarter. Vanguard Personalized Indexing Management LLC now owns 41,935 shares of the medical research company’s stock valued at $5,706,000 after acquiring an additional 1,074 shares during the period. Panagora Asset Management Inc. increased its position in Agilent Technologies by 41.0% in the 4th quarter. Panagora Asset Management Inc. now owns 380,494 shares of the medical research company’s stock valued at $51,774,000 after acquiring an additional 110,667 shares during the period. MML Investors Services LLC increased its position in Agilent Technologies by 109.8% in the 4th quarter. MML Investors Services LLC now owns 59,903 shares of the medical research company’s stock valued at $8,151,000 after acquiring an additional 31,348 shares during the period. Finally, Fieldview Capital Management LLC acquired a new stake in Agilent Technologies in the 4th quarter valued at approximately $2,058,000.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the company. Wells Fargo & Company lowered their price target on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a research report on Thursday, May 28th. Barclays lifted their price target on Agilent Technologies from $140.00 to $145.00 and gave the company an “overweight” rating in a research report on Thursday, May 28th. Wolfe Research reiterated a “hold” rating on shares of Agilent Technologies in a research report on Tuesday, June 2nd. Weiss Ratings upgraded Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, June 2nd. Finally, Bank of America upgraded Agilent Technologies from a “neutral” rating to a “buy” rating and lowered their price target for the company from $150.00 to $145.00 in a research report on Thursday, May 28th. One analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, Agilent Technologies currently has a consensus rating of “Moderate Buy” and a consensus target price of $160.93.

Agilent Technologies Stock Performance

Shares of NYSE A opened at $130.52 on Tuesday. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43. The stock has a market capitalization of $36.86 billion, a price-to-earnings ratio of 26.21, a PEG ratio of 2.31 and a beta of 1.26. The stock’s fifty day simple moving average is $120.55 and its 200 day simple moving average is $127.49. Agilent Technologies, Inc. has a 52-week low of $108.35 and a 52-week high of $160.27.

Agilent Technologies (NYSE:A) last issued its earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.41 by $0.08. The business had revenue of $1.84 billion for the quarter, compared to analysts’ expectations of $1.80 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The company’s quarterly revenue was up 10.0% on a year-over-year basis. During the same period in the previous year, the firm posted $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, sell-side analysts forecast that Agilent Technologies, Inc. will post 6 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 22nd. Investors of record on Tuesday, June 30th will be issued a $0.255 dividend. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Tuesday, June 30th. Agilent Technologies’s payout ratio is presently 20.48%.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.